301096 logo

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Stock Price

SZSE:301096 Community·CN¥5.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

301096 Share Price Performance

CN¥51.19
14.32 (38.84%)
CN¥51.19
14.32 (38.84%)
Price CN¥51.19

301096 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet with minimal risk.

1 Risk
0 Rewards

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Key Details

CN¥590.3m

Revenue

CN¥369.1m

Cost of Revenue

CN¥221.2m

Gross Profit

CN¥409.5m

Other Expenses

-CN¥188.3m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 24, 2026
-1.74
37.48%
-31.89%
37.4%
View Full Analysis

About 301096

Founded
2011
Employees
1451
CEO
Jinfang Lou
WebsiteView website
www.hzbio-s.com

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. operates as a pharmaceutical technology research and development and services company in China. The company primarily provides drug research and development services; and the transformation of research and development technology results for various pharmaceutical, as well as pharmaceutical research and development investment companies. Its business covers the principal links of drug discovery, pharmaceutical research, clinical trials, customized research and development and production, and registration applications. The company was incorporated in 2011 and is headquartered in Hangzhou, China.

Recent 301096 News & Updates

Recent updates

No updates